SCM Pharma is UK-based pharmaceutical contract development and manufacturing organisation (CDMO) that works with clients progressing drugs through clinical trials and others that require commercial supply of niche licensed products.
Specialising in novel, difficult and dangerous products requiring formulation development support and complex fill/finish, the specialist CDMO provides a wide range of development, manufacturing and packaging services to meet client needs.
With specific expertise in custom manufacturing and sterile fill/finish, SCM Pharma is able to handle 14C radiolabeled compounds and highly potent products including cytotoxics. The award-winning CMO can fill liquids, gels and powders in a range of final dosage forms including ampoules, vials, cartridges, syringes and bottles.
Its specialist offerings include –
• Formulation and process development
• Aseptic processing (using isolator technology)
• Non-aseptic processing followed by terminal sterilisation
• Fill/finish of 14C radiolabeled compounds
• Fill/finish of highly potent products including cytotoxic and cytostatic formulations
• Drug/medical device filling and assembly
• In-house testing including sterility, endotoxin, microbiology and analytical chemistry
• ICH stability testing
• Clinical packaging and distribution
• QP release
Privately -owned, SCM Pharma’s corporate HQ and manufacturing facilities are located in Northumberland in the UK with a commercial office in the USA.
Specialties
contract manufacturing organisation (CMO), sterile manufacturing, aseptic processing, cytotoxic products, sterile filling, c14 radiolabled products, formulation development, vial filling, ampoule filling, syringe filling, contract drug manufacturing
